Founded in 2008 by Karl Karlsson and Haraldur Thorsteinsson, 3Z Pharmaceuticals offers research services to develop drugs for neurological disorders. Their drug screening services focus on sleep and epilepsy assays, using disease modeling and behavioral genetics techniques to target new neurological indications. The company leverages fee-for-service screens to provide multiple drug efficacy and toxicity assays, helping in the development of small molecule drugs via drug repurposing.